Home
University & Research Institutions

Sector: University & Research Institutions

Historic CRISPR drug approval heralds new era in Cas9 IP wars

Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.

CRISPR-Cas9 drugmakers like Vertex should come to the table early, says ToolGen’s IP chief

Chief Legal Officer Yoori Kim argues that current patent uncertainty should fuel rather than thwart licensing deals

Patent transactions in Q2 2023

The surge is due to 9,702 US patent assets involved in the BlackBerry sale to Key Patent Innovations, which runs Malikie Innovations, according to the AST Patent Deals Report for Q2 2023

Latest content

$227 million Apollo Therapeutics investment is a major boost for innovative tech transfer approach

Pathbreaking joint venture between academia and Big Pharma addresses university IP monetisation challenges

12 September 2023

RegenxBio/Sarepta dispute highlights strategic challenges for gene therapy developers

Narrow safe harbor immunity and platform technology patents are creating both pitfalls and opportunities

08 September 2023

UPC holds first ever preliminary injunction hearing

NanoString Technologies is facing an injunction at the UPC, which has scheduled several further PI hearings in Munich and Vienna

06 September 2023

‘We want to de-risk the CRISPR-Cas9 patent minefield’, says Sigma-Aldrich IP licensing boss

IAM speaks exclusively to Christopher Arnot about the crowded CRISPR IP landscape

25 August 2023

UPC schedules its first substantive hearings

Having granted its first injunction ex parte, the Unified Patent Court will soon host formal hearings regarding 10x Genomics’ applications for injunctive relief

22 August 2023

We are seeking CRISPR IP partnerships, says SNIPR Biome’s chief patent counsel

IAM speaks exclusively to Jasper Clube about the CRISPR microbiome IP landscape

18 August 2023

Who is who: key players in the global RIS patent landscape

RIS has received attention from a diverse number of players working towards creating SEP portfolios. As the technology progresses and becomes more sophisticated and with the standardisation process underway, an acceleration of patent filings in the coming years is very likely.

02 August 2023

Unlock unlimited access to all IAM content